Pulmonary vascular disease & thromboembolism

Tricuspid-annular-plane-systolic-excursion (TAPSE)/Systolic Pulmonary Artery Pressure (sPAP) Ratio Associated with Increased Mortality in Subjects With and Without Cardiovascular Comorbidities- Insights from a Tertiary Center Database

Eur Heart J Cardiovasc ImagingPublished retrospective analysis

Authors' conclusion

Excess mortality in consecutive subjects performing echocardiography in a tertiary center is seen at higher TAPSE/sPAP values than previously described. The TAPSE/sPAP cutoff associated with excess mortality is influenced by comorbidities and hospitalization status.

Study context

Population
Consecutive subjects, with and without cardiovascular comorbidities, undergoing echocardiography in a single tertiary center between 2011–2021subjects included in the analysis (47% females, median age: 71 y/o, IQR: 58–81)
Participants
17,951 subjects
Exposure
TAPSE/sPAP ratio <0.68 mm/mmHg and mortality
Methodological detailsconsecutive subjects, single tertiary center
  • Consecutive subjects
  • Single tertiary center

Main finding

As reported in the abstract

TAPSE/sPAP threshold associated with excess mortality

TAPSE/sPAP ratio associated with excess mortality

<0.68 mm/mmHg

Observational data: associations, not effects.

Further findings

TAPSE/sPAP threshold associated with excess mortality, by cardiovascular comorbidities (sub-group)

With cardiovascular comorbidities
<0.53 mm/mmHg
Without cardiovascular comorbidities
<0.79 mm/mmHg

Mortality with TAPSE/sPAP ratio <0.68 mm/mmHg (multivariate model)

Adjusted hazard ratio
1.52, 95% confidence interval 1.42-1.63; p < 0.001
  • Adjusted for baseline and echocardiographic parameters

Median TAPSE and sPAP

Median TAPSE
21 mm (IQR: 18-25)
Median sPAP
31 mmHg (IQR: 26-41)

Original publication

TAPSE/sPAP Ratio Associated with Increased Mortality in Subjects With and Without Cardiovascular Comorbidities- Insights from a Tertiary Center Database. Eur Heart J Cardiovasc Imaging. Published 28 September 2026. doi:10.1093/ehjci/jeag275

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.